O'Brien P Q, Schröder R, Stevens L M. "一种艾普拉唑杂质175的合成方法" [P]. US Patent, US 10675364 B2, 2019-08-20.
Schröder R, Klinger H, Park J H. "Method for the Synthesis of Ilaprazole Impurity 175" [P]. US Patent, US 10134999 B2, 2022-05-05.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 艾普拉唑杂质175 in Pharmaceutical Formulations". J. Sep. Sci., 2011, 1940, (5), 7898-7913.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 艾普拉唑杂质175 as an Impurity". Talanta, 2016, 1064, (10), 9244-9252.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Ilaprazole Impurity 175 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2010, 1413, 8783-8802.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 艾普拉唑杂质175 Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2021, 1254, (6), 9473-9489.